HomeAGN • CNSX
add
Algernon Pharmaceuticals Inc
Previous close
$0.090
Day range
$0.090 - $0.095
Year range
$0.060 - $0.17
Market cap
2.58M CAD
Avg Volume
19.40K
P/E ratio
4.69
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 343.88K | -64.92% |
Net income | -372.27K | 62.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -337.90K | 65.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 92.18K | 20.85% |
Total assets | 3.38M | -14.56% |
Total liabilities | 1.96M | -44.20% |
Total equity | 1.42M | — |
Shares outstanding | 37.23M | — |
Price to book | 2.25 | — |
Return on assets | -24.45% | — |
Return on capital | -53.67% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -372.27K | 62.92% |
Cash from operations | -249.42K | -4.34% |
Cash from investing | -15.22K | 34.17% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -265.74K | -12,694.41% |
Free cash flow | -116.98K | -209.41% |
About
Founded
2015
Headquarters
Website
